Your browser doesn't support javascript.
loading
In vivo tau pathology is associated with synaptic loss and altered synaptic function.
Coomans, Emma M; Schoonhoven, Deborah N; Tuncel, Hayel; Verfaillie, Sander C J; Wolters, Emma E; Boellaard, Ronald; Ossenkoppele, Rik; den Braber, Anouk; Scheper, Wiep; Schober, Patrick; Sweeney, Steven P; Ryan, J Michael; Schuit, Robert C; Windhorst, Albert D; Barkhof, Frederik; Scheltens, Philip; Golla, Sandeep S V; Hillebrand, Arjan; Gouw, Alida A; van Berckel, Bart N M.
Afiliação
  • Coomans EM; Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. e.coomans@amsterdamumc.nl.
  • Schoonhoven DN; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. e.coomans@amsterdamumc.nl.
  • Tuncel H; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Verfaillie SCJ; Department of Clinical Neurophysiology and MEG Center, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Wolters EE; Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Boellaard R; Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Ossenkoppele R; Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • den Braber A; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Scheper W; Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Schober P; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Sweeney SP; Clinical Memory Research Unit, Lund University, Lund, Sweden.
  • Ryan JM; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Schuit RC; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Windhorst AD; Department of Clinical Genetics, Amsterdam Neuroscience, Amsterdam UMC, Amsterdam, The Netherlands.
  • Barkhof F; Center for Neurogenomics and Cognitive Research, Department of Functional Genomics, Faculty of Science, Vrije Universiteit, Amsterdam, The Netherlands.
  • Scheltens P; Department of Anaesthesiology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Golla SSV; Rodin Therapeutics Inc., Cambridge, MA, USA.
  • Hillebrand A; Rodin Therapeutics Inc., Cambridge, MA, USA.
  • Gouw AA; Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • van Berckel BNM; Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Alzheimers Res Ther ; 13(1): 35, 2021 02 05.
Article em En | MEDLINE | ID: mdl-33546722
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Alzheimers Res Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Alzheimers Res Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda